News
At just 12mm thick and 14mm wide, EmbraceMini is the smallest wristworn actigraphy device for clinical research in the world – the size of an AA battery. It is purpose-made for studies that track ...
The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an ...
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare ...
2h
HealthDay on MSNADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 DiabetesThe oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...
Glucotrack reported positive clinical results for its implantable glucose monitor, aiming to offer a less-intrusive option ...
Tapping into the hidden job market can be challenging but is important in today’s employer-driven market. Three talent ...
This updated asthma guideline establishes a consistent approach to improving asthma diagnosis and control in adults and ...
Duchenne muscular dystrophy is characterized by a mutation in the DMD gene that leads to a lack of dystrophin and muscle loss ...
Vidhu Thaker, M.D., Pediatric Endocrinology, Columbia University, New York City will present a poster from the 14-week, multicenter, international, randomized, double-blind, placebo-controlled Phase 2 ...
The cumulative data from the Phase 1 study indicate that salanersen has a generally well tolerated safety profile at both the 40 mg and 80 mg doses, with most adverse events (AEs) mild to moderate in ...
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott's new head of diabetes business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results